Sir,
Ocular surface squamous neoplasia (OSSN) has the potential for causing significant ocular and systemic morbidity and mortality. We present two cases of invasive OSSN successfully treated with proton beam therapy (PBT). Both were non-resectable due to deeper scleral invasion.
Case reports
Case 1
A 73-year-old patient was referred to the Ocular Oncology Service with a nodular lesion in the lower fornix (Figure 1a). Incisional biopsy revealed widespread carcinoma in situ with invasive focus (Figures 1c and d). Four cycles of topical MytomycinC (MMC, 0.02%) were administered; however, tumour growth continued.
Hence treatment with PBT was recommended. Treatment planning was guided by measurement of tumour dimensions using ultrasonography.
Four fractions of 5310 cGy were given over 4 days. The lesion resolved completely over several months (Figure 1b). The patient remains recurrence free for 2 years as confirmed by serial map biopsies (Figure 1e).
Case 2
An 83-year-old patient was referred with a large limbal lesion encroaching on the cornea (Figure 1f).
Incisional biopsy revealed invasive OSSN (Figures 1h and i).
Treatment with PBT was administered primarily as described above.
Complete resolution at 3 months was found. The patient remains recurrence free at year follow-up.
Comment
The standard treatment for OSSN is surgical excision with safety margin and cryotherapy to the edges.1 MMC, 5-fluorouracil, interferon,2 and radiotherapy (including external beam radiotherapy and brachytherapy)3 have been used as adjuvant treatment with variable success rates.
PBT, a type of external beam radiotherapy, delivers a high dose of ionizing radiation to the tumour with minimal damage to surrounding tissues. It has been used successfully to treat head and neck SCCs,4 carcinomas elsewhere,5 as well as other ocular tumours (mainly choroidal melanoma).6 Only one case is reported in the literature for which PBT was successfully used as primary treatment for invasive OSSN7 and we report the first two successful cases in United Kingdom. A case series in which PBT was used for recurrent OSSN or where the surgical margins were involved after excision was published with encouraging results.8
In both presented cases, PBT has regressed the tumour without recurrence. Both patients received a 6-week course of topical steroids post treatment. No immediate side effects were noted, however one developed a cataract 2 years later, and the second developed a patch of scleral thinning that was stable on follow-up. We suspect it was an area of deeper tumour invasion that melted away with treatment (Figure 1g).
We believe that PBT should be considered for OSSN when surgical excision is not possible.
References
Lee GA, Hirst LW . Ocular surface squamous neoplasia. Surv Ophthalmol 1995; 39: 429–450.
Basti S, Mascai MS . Ocular surface squamous neoplasia. Cornea 2003; 22 (7): 687–704.
Stannard C, Sauerwein W, Maree G, Lecuona K . Radiotherapy for ocular tumours. Eye (Lond) 2013; 27 (2): 119–127.
Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011; 81 (5): 1473–1478.
Oshiro Y, Mizumoto M, Okumura T, Hashimoto T, Fukumitsu N, Ohkawa A et al. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer. J Thorac Oncol 2012; 7 (2): 370–375.
Fuss M, Loredo LN, Blacharski PA, Grove RI, Slater JD . Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001; 49 (4): 1053–1059.
Ramonas KM, Conway RM, Daftari IK, Crawford JB, O'Brien JM . Successful treatment of intraocularly invasive conjunctival squamous cell carcinoma with proton beam therapy. Arch Ophthalmol 2006; 124 (1): 126–128.
Caujolle JP, Maschi C, Chauvel P, Herault J, Gastaud P . Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results. J Fr Ophtalmol 2009; 32 (10): 707–714.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
El-Assal, K., Salvi, S., Rundle, P. et al. Treatment of invasive ocular surface squamous neoplasia with proton beam therapy. Eye 27, 1223–1224 (2013). https://doi.org/10.1038/eye.2013.149
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2013.149
This article is cited by
-
Ocular surface squamous neoplasia: management and outcomes
Eye (2021)
-
Comment on: Proposal for a new classification for ocular surface squamous neoplasia
Eye (2019)
-
Evaluation of the radiotherapy management of ocular surface squamous neoplasia in a high HIV prevalence setting- a retrospective review
Infectious Agents and Cancer (2016)